Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
NATIONAL INSTITUTES OF HEALTH has floated a tender for Single Source for Continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (Hpap-T2d) (U01 Clinical Trial not Allowed). The project location is USA and the tender is closing on 28 Feb 2024. The tender notice number is RFA-DK-25-002, while the TOT Ref Number is 91083551. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Single Source for Continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (Hpap-T2d) (U01 Clinical Trial not Allowed)
Deadline : 28 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 91083551
Document Ref. No. : RFA-DK-25-002
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
CFDA Number : 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Feb 28, 2024
Posted Date : Oct 24, 2023
Description: This Notice of Funding Opportunity (NOFO) invites cooperative agreement applications to expand the operational scope of the existing Human Pancreas Analysis Program (HPAP) to the study of pancreata recovered from tissue donors with Type 2 Diabetes (T2D) and related metabolic disorders. This NOFO will support one team of investigators with combined expertise in human pancreas physiology and pathophysiology; collection, processing and multimodal analysis of human pancreatic tissues; and biological database building, curation and management, that will be tasked to: 1) identify, collect and intensively characterize primary pancreatic tissues from patients with T2D and related forms of islet dysfunction, as well as age-matched controls; and 2) analyze, organize and share the data resulting from the study of these tissues through use and expansion of the existing PANC DB open-access resource database. HPAP is a component of the Human Islet Research Network (HIRN), created in 2014 to support innovative and collaborative translational research to understand how human beta cells are lost in Type 1 Diabetes (T1D), and to find innovative strategies to protect and replace functional human beta cell mass.
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google